会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • SN-2 MYRISTATE-CONTAINING EDIBLE OIL
    • SN-2含糖食品
    • WO2010027433A2
    • 2010-03-11
    • PCT/US2009/004860
    • 2009-08-25
    • BRANDEIS UNIVERSITYPERLMAN, DanielHAYES, Kenneth, C.
    • PERLMAN, DanielHAYES, Kenneth, C.
    • A61K31/231
    • C11C3/10A23D9/02A23L33/12
    • A nutritional fat or oil-based composition for increasing HDL cholesterol, decreasing LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma is described. The composition can advantageously include at least 1 % by weight myristic acid esterified at the sn-2 position in triglyceride molecules, includes between 10% and 40% by weight linoleic acid, and further includes between 30% and 65% by weight oleic acid and between 15% and 40% by weight total saturated fatty acids. The ratio of sn-2 myristic acid to sn-2 palmitic acid is typically greater than 1 :1 and the sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free.
    • 描述了用于增加HDL胆固醇,降低LDL胆固醇和降低人血浆中LDL / HDL胆固醇比例的营养型油脂或组合物。 该组合物可以有利地包括在甘油三酯分子中在sn-2位置酯化的至少1重量%的肉豆蔻酸,包括10重量%至40重量%的亚油酸,并且还包含30重量%至65重量%的油酸和 15%至40%(重量)的总饱和脂肪酸。 sn-2肉豆蔻酸与sn-2棕榈酸的比例通常大于1:1,饱和,单不饱和和多不饱和脂肪酸的重量百分比之和等于100%。 在期望的情况下,组合物基本上不含胆固醇。